Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
10 mục trên mỗi trang (Trang 1 / 1) Tổng số 4 mục
11-20
11-03
11-02
10-27
10-10
10-07
10-07
09-20
09-14
08-07
